Clinical Trial Update: Irinotecan With or Without Capecitabine as Second-Line Therapy in Treating Older Patients With Progressive, Metastatic Colorectal Cancer That Cannot Be Removed By Surgery [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating irinotecan with or without capecitabine as second-line therapy in older patients with progressive, metastatic colorectal cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Camptosar (irinotecan)
• Xeloda (capecitabine)

Snippet

Sponsor: Federation Francophone de Cancerologie Digestive | Conditions: Colorectal Cancer | Phase 2 | Status: UNKNOWN